Methoxphenidine / MXP acts as a selective antagonist at the NMDA receptor and is also acts on the dopamine transport, inhibiting the reuptake of dopamine defining the compound also a (DRI dopamine reuptake inhibitor).
Based on this, it is useful to researchers for in vitro modelling of NMDA & Dopamine transport interaction. Researchers may also use MXP as a reference sample for their GC/MS, FTIR or NMR analysis catalogue.It is the 2-methoxy analogue of Diphenidine which we recently launched and is already proving very popular amongst researchers. Other well known NMDA receptor antagonists include Ketamine, Methoxetamine and 4-MeO-PCP.This is a superior fine chemical compared with diphenidine, but has the added benefit of being more approachable for the casual researcher.Researchers carrying out reports on this compound will need to be equipped with scales capable of weighing as low as 50-100mg of material accurately.
The liquid is a suspension containing the new cannabinoid: N-cumyl-1-(5-fluropentyl) indazole-3-carboxamide, the very first time this exclusive patent pending cannabinoid has been seen in the UK!For sale to over 18's only. Not approved for human consumption.
Herb, a unique blend of herbal and and nature identical compounds, designed for use as a ceremonial incense.Contains - Mullein, Hemp, Humulus Lupulus, Natural and nature identical aromatic compounds.Not for human consumption.New to website 14/03/13